latest update:
[RxAtlas]

drug summary · 6 NDC codes

BENLYSTA 200 mg/mL

belimumab

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 109060NDC codes 6application BLA761043RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic namebelimumab
active ingredientsBELIMUMAB
dosage formSOLUTION
routeSUBCUTANEOUS
strength200 mg/mL
marketing statusBLA
DEA schedulenot reported
application numberBLA761043
ATC codenot reported
RxCUInot reported
manufacturerGlaxoSmithKline LLC
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classB Lymphocyte Stimulator-directed Antibody Interactions [MoA]; B Lymphocyte Stimulator-specific Inhibitor [EPC]; Decreased B Lymphocyte Activation [PE]

NDC codes

6 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
49401-088—
49401008802—
49401008835—
49401008847—
49401008850—
49401008861—

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.